Pharmacopeia (PCOP) Reports Q2 Loss of $0.53, Misses by 10c
More News related to PCOP
- Pharmacopeia to Request a Hearing With NASDAQ Following Receipt of Notice of Non-Compliance
- Pharmacopeia (PCOP) Tops Q3 View By 20c
- Ligand Pharmaceuticals Announces Third Quarter Results
- Pharmacopeia Announces Third Quarter 2008 Financial Results
- Trading Radar for 11/06: Disney (DIS), Anheuser-Busch (BUD), NVIDIA (NVDA), Nasdaq (NDAQ), Toyota (TM), Priceline.com (PCLN) Reports; Initial Jobless Claims, Preliminary Productivity for Q3 Due
More News related to Earnings
- BMO Upgrades Spectrum Brands (SPC) to Market Perform
- Maxim Upgrades Palomar Medical (PMTI) to Buy
- RBC Capital Upgrades DSP Group (DSPG) to Sector Perform
- UBS Upgrades Morgans Hotel Group (MHGC) to Buy
- Janney Montgomery Scott Upgrades Wright Express Corp (WXS) to Buy.
Pharmacopeia (Nasdaq: PCOP) reports a Q2 loss of $0.53, 10 cents worse than the analyst estimate of ($0.43). Revenues for the quarter were $5.9 million, versus the consensus of $6.43 million.
Related Categories
EarningsStocks Mentioned
+0.06Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
